Your browser doesn't support javascript.
loading
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
Polvani, Simone; Martignano, Filippo; Scoccianti, Guido; Pasqui, Adriano; Palomba, Anna Rita; Conticello, Silvo; Galli, Andrea; Palchetti, Ilaria; Caporalini, Chiara; Antonuzzo, Lorenzo; Campanacci, Domenico Andrea; Pillozzi, Serena.
Affiliation
  • Polvani S; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence.
  • Martignano F; Core Research Laboratory, ISPRO, Firenze.
  • Scoccianti G; Orthopaedic Oncology Unit.
  • Pasqui A; Medical Oncology Unit, Florence.
  • Palomba AR; Histopathology and Molecular Diagnostic Unit, Careggi University Hospital.
  • Conticello S; Core Research Laboratory, ISPRO, Firenze.
  • Galli A; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence.
  • Palchetti I; Department of Chemistry Ugo Schiff, Univerisity of Florence, Sesto Fiorentino.
  • Caporalini C; Pathology Unit, Anna Meyer Children's University Hospital.
  • Antonuzzo L; Medical Oncology Unit, Florence.
  • Campanacci DA; Department of Experimental and Clinical Medicine, University of Florence.
  • Pillozzi S; Orthopaedic Oncology Unit.
Anticancer Drugs ; 33(3): 278-285, 2022 03 01.
Article in En | MEDLINE | ID: mdl-35045526

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / RNA, Long Noncoding Type of study: Prognostic_studies Limits: Adolescent / Child / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / RNA, Long Noncoding Type of study: Prognostic_studies Limits: Adolescent / Child / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article